We report on a protein kinase function encoded by the unique N terminus of the herpes simplex virus type 1 (HSV-1) ribonucleotide reductase large subunit (R1). Rl expressed in Escherichia coli exhibited autophosphorylation activity in a reaction which depended on the presence of the unique N terminus. When the N terminus was separately expressed in E. coli and partially purified, a similar autophosphorylation reaction was observed. Importantly, transphosphorylation of histones and of proteins in HSV-1-infected cell extracts was also observed with purified Rl and with truncated Rl mutants in which most of the N terminus was deleted. Ion-exchange chromatography was used to separate the autophosphorylating activity of the N terminus from the transphosphorylating activity of an E. coli contaminant protein kinase. We propose a putative function for this activity of the HSV-1 Rl N terminus during the immediate-early phase of virus replication.
Ribonucleotide reductase (EC 1.17.4.1) catalyzes a ratelimiting step in the de novo synthesis of DNA, converting ribonucleoside diphosphates to the corresponding deoxyribonucleoside diphosphates (37) . Herpes simplex virus type 1 (HSV-1) and HSV-2 both encode ribonucleotide reductase (7, 8, 11, 14, 30, 36) comprising a large subunit (R1; molecular mass, 136 kDa) and a small subunit (R2; molecular mass, 38 kDa), present in an a2132 heterodimer (2, 10, 14, 18) . The Rl subunit contains the nucleotide-binding site and redox-active thiols, whereas the R2 subunit has two binuclear iron centers and provides the tyrosyl free radical involved in ribonucleoside diphosphate reduction (28, 33, 34) . Amino acid sequence analysis indicates distinct homologies between HSV ribonucleotide reductase and the ribonucleotide reductases encoded by Epstein-Barr virus, varicella-zoster virus, vaccinia virus, Escherichia coli, bacteriophage T4, and mouse DNA (13) . However, a feature unique to the Rl subunits of HSV-1 and HSV-2 is an N-terminal extension of some 320 amino acids which is absent from the Ri subunits of other species (27) ; for HSV-1, this N-terminal extension is unnecessary for ribonucleotide reduction in vitro (9, 13, 21) .
HSV-1 and HSV-2 possess a protein kinase activity located within the unique N terminus of Ri (1, 3, 4, 29) . In these studies, HSV Rl proteins, immunoprecipitated either from infected-cell extracts or from cells transfected with constitutive expression vectors, were observed to auto-and transphosphorylate. Expression of the N terminus of HSV-2 Ri in E. coli followed by its immunoprecipitation as a 29-kDa protein yielded, on analysis, a protein kinase activity (23) .
Here we locate and characterize the phosphorylating activity of the HSV-1 Rl N terminus with (i) purified Rl expressed in E. coli, here termed EcRi, (ii) the N-terminal amino acids of Rl expressed separately in E. coli, and (iii) N-terminal truncations of Rl as reagents. HSV-1 Ri expressed in E. coli (EcR1) was purified as previously de-* Corresponding author.
scribed (15) . Plasmid pAET, encoding the truncated Rl mutant dN245R1, was prepared by deletion of the nucleotides encoding Rl amino acids 1 to 245 from the EcRlexpressing clone pETR1 type 1 (15) with exonuclease III and mung bean nuclease (Fig. 1) . The remaining Rl portion was then inserted between the promoter and terminator of the expression vector pAET8C, a modification of pET8C (35) in which the backbone of the vector (pBR322) has been replaced by pAT153. Full details of this construct and the library of Rl truncations from which it was selected will be given elsewhere (14a). The expressed protein, termed dN245R1, was purified from E. coli extracts as described for intact EcRl (15) .
The first 449 amino acids of Rl were expressed in E. coli BL21 cells by using a modified pET vector (Fig. 1) . The truncation was made by cutting the full-length Rl clone pYN-Rl (27) with BstXI, and the end was rendered blunt with mung bean exonuclease. A new HindIII site was created by addition of linkers to the blunt BstXI site, allowing the truncated Rl open reading frame to be removed on an XbaI-HindIII fragment for cloning into pET8C (the BamHI site was filled in and HindIII linkers were added). The construct was confirmed by sequencing by the doublestranded dideoxy termination method (17, 32) . pETdC449R1 was induced as described previously for full-length EcRl (15) .
The truncations dN246R1 and dN305R1 were prepared by proteolysis of purified EcRl with chymotrypsin and trypsin, respectively (9) ; both proteases cleave at specific sites within the N terminus, chymotrypsin at amino acid 246 and trypsin at amino acid 305 (Fig. lb) (9) , and hence it is not shown.
of 3 x sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer (20) . Incorporation of 2P was determined by autoradiography of SDS-polyacrylamide gels. Bands corresponding to Rl were excised from the gel, and 32P incorporation was quantified by liquid scintillation counting. Figure 2a shows optimization of NaCl and Mn2+ concentrations for EcRi autophosphorylation. Optimum activity occurred at 250 mM NaCl (Fig. 2a, lanes 1 to 4) , and the reaction had an absolute requirement for Mn2" (Fig. 2a , lanes 5 and 6), although concentrations of Mn2" above 0.5 mM did not affect autophosphorylation ( (lanes 2 and 3, respectively), purified dN245R1 (lane 4), and Rl obtained from the 45% (NH4)2SO4 fraction of infectedcell extracts (lane 5) isolated with an HSV-1 R2 affinity matrix as described before (9); lane 6 represents the result of incubating the R2 affinity matrix with the equivalent fraction from mock-infected cells. The 45% (NH4)2SO4 fractions from either HSV-1 strain 17+-infected or mock-infected baby hamster kidney C13 cells were prepared as described by Dutia et al. (12) . autophosphorylation (Fig. 2c, lanes 1 and 5) . Treatment of intact EcRl with trypsin generated a 30-kDa N-terminal fragment (9) which autophosphorylated (Fig. 2c, lane 2) . This 30-kDa N-terminal fragment stains very poorly with Coomassie blue (9) and cannot be seen in Fig. 2b ; however, it was detected by Western immunoblotting in this preparation. No phosphorylating activity was observed with the N-terminal truncations dN246R1 and dN245R1 (Fig. 2c,  lanes 3 and 4) or the R2 affinity matrix incubated with mock-infected-cell extract (Fig. 2c, lane 6) . Peptide mapping (6) was performed on autophosphorylated EcRl or Ri from infected-cell extracts, and the results indicated that identical peptides were phosphorylated (Fig. 2d) .
The induction by isopropylthiodigalactoside of a novel 46-kDa protein in whole-cell extracts of E. coli transfected with the plasmid pETdC449R1 is shown in Fig. 3a . This novel protein reacted with the HSV-1 Ri-specific monoclonal antibody 1026 (24), the epitope for which maps within the N-terminal domain, on Western blotting (Fig. 3b) . The additional faint bands occurring with EcRl and the Ri N terminus are the result of degradation and were not observed consistently. Optimum precipitation of this 46-kDa protein was achieved with 45% (NH4)2SO4, and when this fraction was assayed under EcRl kinase assay conditions, the protein was phosphorylated (Fig. 3c) ; the other phosphorylated bands are E. coli proteins and were consistently observed in both induced and uninduced cell extracts. The 46-kDa phosphorylated Ri protein reacted with the monoclonal antibody 1026 in Western blots, and only this protein had requirements similar to those of intact Ri for Mn2' and NaCl (data not shown). These data suggest that the autophosphorylating activity resides entirely within the N-terminal 449 amino acids of Ri.
Substrate specificity and inhibitors. When EcRl autophosphorylation was assayed in the presence of unlabeled ATP or GTP, incorporation of 32p was inhibited. Figure 4a shows (AMP-PNP) and 5'-fluorosulfonylbenzoyladenosine (FSBA) both inhibited EcRi autophosphorylation. Inhibition by AMP-PNP was similar to that by unlabeled ATP or GTP (Fig. 4b) (Fig. 5a, lanes 1, 2, and   7 ). The additional band in lane 2 is the 30-kDa N-terminal fragment produced by trypsin treatment of EcRl, which retains autophosphorylating activity. When histones or the heat-inactivated proteins were incubated under identical conditions but without EcRl, no phosphoprotein bands were observed (Fig. 5a, lanes 5 and 6) . Significantly, when the two N-terminal deletions dN245R1 and dN246R1 were incubated with histones, phosphorylated proteins identical to those observed with EcRl were seen (Fig. 5a, lanes 3 and 4) . Phosphorylation also occurred when dN245R1 was incubated with heat-inactivated infected-cell proteins (Fig. 5a, lane 8) . As these truncations have most of the Rl N terminus deleted, we conclude that the transphosphorylating activity is not associated with the unique N terminus but is the result of a contaminant E. coli protein kinase. This was confirmed by fast protein liquid chromatography (FPLC) on a Mono Q ion-exchange column, which separated EcRl autophosphorylation from histone transphosphorylation (Fig. Sb) . This was achieved by applying purified EcRl to a Mono Q column and eluting bound protein with a 0 to 0.5 M NaCl gradient developed over 15 ml. Every third fraction of this gradient was desalted with an FPLC fast-desalt column and assayed for EcRl autophosphorylation and histone transphosphorylation. EcRl autophosphorylation was observed in fraction 15, whereas histone phosphorylation occurred in fraction 9.
These studies demonstrate the presence of an autophosphorylating activity associated with the unique N terminus of HSV-1 Rl. This activity resembles protein kinase activities in that it is inhibited by the ATP analogs AMP-PNP and FSBA. Despite using a variety of known substrates for other protein kinases, we were unable to observe any transphosphorylation activity. Our Our results do not exclude the formal possibility that the kinase activity associated with the N terminus of HSV-1 Rl differs from that of the N terminus of HSV-2 Rl, since the amino acid sequences of these regions show only limited homology (27) and there is a candidate lysine residue in the HSV-2 Rl N terminus (4). Paradis et al. (29) , in their explanation of HSV-1 Rl kinase activity, speculated that the HSV-1 DNA sequence was incorrect and should contain a lysine equivalent to that in the HSV-2 Rl sequence, at amino acid 180. Two independent HSV-1 Rl clones have been sequenced which predict no lysine (25, 27) , and the sequence of our clone, which expresses the 46-kDa N-terminal portion, agrees with these previously determined sequences (data not shown). Recently, Luo and Aurelian (22) have shown that the candidate lysine in HSV-2 Rl is not required for activity, which suggests that there may be some similarity in the reaction mechanisms of the two proteins.
During the restricted immediate-early phase of virus replication, the HSV-1 Rl polypeptide is present together with five other virus proteins which act to regulate expression of virus early and late genes (5, 38) . The Rl promoter, which contains virus immediate-early motifs, is regulated as an immediate-early function (40) , in contrast to the R2 gene, which behaves as a typical early function. This suggests a role for Rl during immediate-early infection which is distinct from ribonucleotide reductase activity. The phosphorylated Rl N terminus could function as a protein kinase during the immediate-early phase and phosphorylate at restricted sites on virus immediate-early or cellular proteins, thereby affecting transcriptional activity. In this regard, the hepatitis B virus-encoded Hbx protein exhibits autophosphorylation and acts as a transcriptional activator; transactivation is achieved by a serine/threonine kinase activity which shows no amino acid homology to "conventional" kinases (39 
